WCM Investment Management
BHVN

WCM Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

WCM Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-56,823
Closed -$6.74M – 222
2022
Q1 		$6.74M Sell
56,823
-7,948
-12% -$991K 0.02% 137
2021
Q4 		$8.93M Buy
64,771
+3,737
+6% +$475K 0.02% 135
2021
Q3 		$8.48M Sell
61,034
-21,179
-26% -$2.64M 0.02% 132
2021
Q2 		$7.98M Buy
82,213
+3,271
+4% +$265K 0.02% 132
2021
Q1 		$5.4M Sell
78,942
-1,716
-2% -$139K 0.01% 136
2020
Q4 		$6.91M Buy
80,658
+14,989
+23% +$1.27M 0.02% 131
2020
Q3 		$4.27M Buy
65,669
+3,919
+6% +$257K 0.02% 140
2020
Q2 		$4.51M Buy
61,750
+2,235
+4% +$119K 0.02% 131
2020
Q1 		$2.02M Buy
59,515
+17,226
+41% +$788K 0.01% 149
2019
Q4 		$2.3M Buy
42,289
+26,481
+168% +$1.31M 0.01% 143
2019
Q3 		$660K Buy
15,808
+6,990
+79% +$295K ﹤0.01% 134
2019
Q2 		$386K Sell
8,818
-132
-1% -$7.44K ﹤0.01% 145
2019
Q1 		$461K Buy
+8,950
New +$387K ﹤0.01% 136

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WCM Investment Management's BHVN Position: Q2 2022 in Review

WCM Investment Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2022, closing a stake of 56,823 shares — an estimated $6.74M sold.

WCM Investment Management first reported a position in BHVN in Q1 2019 and held it in 13 quarters. The position peaked at $8.93M in Q4 2021. 329 funds tracked by Wall St. Rank hold BHVN as of Q2 2022.

  • WCM Investment Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2022 after selling out during the quarter.
  • WCM Investment Management sold 56,823 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2022, an estimated $6.74M.
  • WCM Investment Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2019 and held it in 13 quarters.
  • WCM Investment Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $8.93M in Q4 2021.
  • 329 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2022.

Based on WCM Investment Management's 13F filing for Q2 2022, filed 9 Aug 2022.